PRIMAVERA (PRedicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial ResistAnce):

A NEW OPEN SOURCE PLATFORM FOR THE STUDY OF MONOCLONAL ANTIBODIES AND VACCINES ON ANTIMICROBIAL RESISTANCE

A 5-year project, funded by IMI with 9 million euro, involving 19 partners from EU countries, the United Kingdom and Russia, 16 academic institutions and stakeholders including pharmaceutical companies.

The ID-CARE team of the University of Verona led by Prof. Tacconelli is a partner in the project.

With an innovative evidence-based approach, the project aims to develop an open-source platform that allows faster and more effective access to relevant epidemiological data including both health and economic data- and to prioritize research and development of strategies to reduce the burden of antimicrobial resistance.

See Italian media for relevant articles:

https://www.mattinodiverona.it/2022/01/26/univr-progetto-primavera-uno-studio-per-combattere-lantibiotico-resistenza/

https://www.ansa.it/canale_saluteebenessere/notizie/medicina/2022/01/26/anticorpi-monoclonali-per-battere-lantibiotico-resistenza_e5a3510c-0f9f-495c-b707-7bd0ab5581dd.html

https://av.mimesi.com/play?v=UniVerona/24189821-7dee-11ec-b000-005056913153.mp4

https://tgverona.telenuovo.it/amp/attualita/2022/01/26/anticorpi-per-combattere-lantibiotico-resistenza-lateneo-partecipa-a-un-progetto-europeo

https://www.insalutenews.it/in-salute/anticorpi-monoclonali-per-combattere-lantibiotico-resistenza-al-via-il-progetto-primavera/

https://www.veronasera.it/attualita/universita-verona-tacconelli-resistenza-antibiotici-26-gennaio-2022.html

https://www.larena.it/territori/citt%C3%A0/l-universita-di-verona-con-evelina-tacconelli-partner-del-progetto-primavera-per-battere-l-antibiotico-resistenza-1.9150228

Direct access to the Primavera project website is here:

www.primavera-amr.eu